Rchr
J-GLOBAL ID：201801015093293059   Update date: Dec. 06, 2024

Atsushi Takano

Atsushi Takano
Affiliation and department：
Shiga University of Medical Science Department of Molecular Oncology

About Shiga University of Medical Science Department of Molecular Oncology


Other affiliations (1)：
Research field  (1)： Internal medicine - General
Research keywords  (1)： lung cancer
Research theme for competitive and other funds  (5)：
  • 2019 - 2022 Identification of biomarker and therapeutic target for lung cancer
  • 2016 - 2019 Clinical application of high sensitive biomarker and therapeutic target for lung cancer
  • 2010 - 2016 Scientific Support Programs for Cancer Research Grant-in-Aid for Scientific Research on Innovative Areas
  • 2012 - 2015 Identification of new biomarkers and therapeutic targets for lung cancer
  • 2010 - 2011 Identification of biomarker and therapeutic target for lung cancer
Papers (104)：
  • Hidetoshi Sumimoto, Satoshi Noda, Hiroyoshi Koide, Yutaro Douke, Kosuke Sakai, Akihito Nishikawa, Azumi Tomioka, Maki Hori, Hiromi Nakato, Yuri Kimura, et al. Pre-existing autoimmune disease as a risk factor for immune-related adverse events in cancer patients receiving immune checkpoint inhibitors. PLOS ONE. 2024. 19. 7. e0306995-e0306995
  • Hiroko Yaegashi, Yukikazu Hayashi, Makoto Takeda, Shih-Wei Chiu, Haruhiko Nakayama, Hiroyuki Ito, Atsushi Takano, Masahiro Tsuboi, Koji Teramoto, Hiroyuki Suzuki, et al. Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology. Therapeutic innovation & regulatory science. 2024
  • Regina Wachuka Mbugua, Atsushi Takano, Bayarbat Tsevegjav, Tomoyuki Yokose, Toshinari Yamashita, Yohei Miyagi, Yataro Daigo. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer. International journal of oncology. 2024. 64. 4
  • 住本 秀敏, 高野 淳, 寺本 晃治, 醍醐 弥太郎. 免疫チェックポイント阻害剤(ICI)投与後の免疫関連有害事象(irAE)における自己免疫疾患(AI)合併のリスク評価. 日本内科学会雑誌. 2024. 113. 臨増. 188-188
  • 高野 淳, 寺本 晃治, 住本 秀敏, 醍醐 弥太郎. 大学病院における希少がん治療の現状に関するがん薬物療法レジメン運用状況からの考察. 日本内科学会雑誌. 2024. 113. 臨増. 189-189
ｍore...
MISC (149)：
  • MBUGUA Regina, MBUGUA Regina, TAKANO Atsushi, TAKANO Atsushi, TAKANO Atsushi, TSEVEGJAV Bayarbat, TSEVEGJAV Bayarbat, MIYAGI Yohei, DAIGO Yataro, DAIGO Yataro, et al. Molecular characterization of URST7 as a novel prognostic biomarker and therapeutic target for breast cancer. 日本臨床腫瘍学会学術集会(CD-ROM). 2023. 20th
  • 高野 淳, 住本 秀敏, 寺本 晃治, 醍醐 弥太郎. 大学病院でのがん薬物療法レジメン管理と希少・難治がんレジメン運用の現状. 日本内科学会雑誌. 2022. 111. Suppl. 220-220
  • 高野淳, 高野淳, 高野淳, 宮城洋平, 醍醐弥太郎, 醍醐弥太郎, 醍醐弥太郎. 肺がんの新規予後マーカー,治療標的分子URST1の同定. 日本人類遺伝学会大会プログラム・抄録集. 2022. 67th
  • BAYARBAT Tsevegjav, BAYARBAT Tsevegjav, TAKANO Atsushi, TAKANO Atsushi, TAKANO Atsushi, ZHU Ming, ZHU Ming, YOSHITAKE Yoshihiro, SHINOHARA Masanori, DAIGO Yataro, et al. HJURP as a prognostic biomarker and therapeutic target for oral cancer. 日本人類遺伝学会大会プログラム・抄録集. 2022. 67th
  • TSEVEGJAV Bayarbat, TSEVEGJAV Bayarbat, TAKANO Atsushi, TAKANO Atsushi, TAKANO Atsushi, ZHU Ming, ZHU Ming, YOSHITAKE Yoshihiro, SHINOHARA Masanori, DAIGO Yataro, et al. Potential role of URST5 as a prognostic biomarker and therapeutic for oral cancer. 日本臨床腫瘍学会学術集会(CD-ROM). 2022. 19th
ｍore...
Lectures and oral presentations  (101)：
  • 化学療法レジメン管理の後方視研究
    (日本内科学会雑誌 2018)
  • 新規予後バイオマーカーと乳癌の治療標的としてのURST1の同定
    (日本癌学会総会記事 2017)
  • 口腔癌における新規予後予測マーカー・治療ターゲットであるUROC4の機能解析
    (日本癌学会総会記事 2017)
  • 呼吸器系腫瘍の新規バイオマーカー、治療標的分子URST1の同定
    (日本癌学会総会記事 2017)
  • 次世代シークエンス法を用いた肺癌ネオアンチゲン候補の同定
    (日本癌学会総会記事 2017)
ｍore...
Education (2)：
  • 2004 - 2009 Hiroshima University Faculty of Medicine Graduate School of Medical Sciences
  • 1991 - 1997 Hiroshima University
Professional career (1)：
  • Doctor of Philosophy (Hiroshima University)
Work history (4)：
  • 2024/05 - 現在 Institute of Medical Science, The University of Tokyo
  • 2022/06 - 現在 Shiga University of Medical Science
  • 2010/04 - 現在 Shiga University of Medical Science Department of Medical Oncology
  • 2014/09 - 2023/04 The University of Tokyo
Association Membership(s) (7)：
Japanese Society of Palliative Medicine ,  American association of cancer research ,  American society of clinical oncology ,  THE JAPAN SOCIETY OF HUMAN GENETICS ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE RESPIRATORY SOCIETY ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM